GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Cyclically Adjusted PB Ratio

Merus Labs International (Merus Labs International) Cyclically Adjusted PB Ratio : (As of May. 05, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Merus Labs International Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Merus Labs International's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Cyclically Adjusted PB Ratio Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Merus Labs International's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Cyclically Adjusted PB Ratio falls into.



Merus Labs International Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Merus Labs International's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2017 is calculated as:

For example, Merus Labs International's adjusted Book Value per Share data for the three months ended in Mar. 2017 was:

Adj_Book=Book Value per Share/CPI of Mar. 2017 (Change)*Current CPI (Mar. 2017)
=1.194/102.6337*102.6337
=1.194

Current CPI (Mar. 2017) = 102.6337.

Merus Labs International Quarterly Data

Book Value per Share CPI Adj_Book
200706 3.960 88.412 4.597
200709 4.564 88.412 5.298
200712 4.742 88.491 5.500
200803 4.680 88.965 5.399
200806 4.579 91.177 5.154
200809 3.540 91.414 3.974
200812 2.942 89.518 3.373
200903 2.755 90.071 3.139
200906 2.905 90.940 3.279
200909 2.336 90.624 2.646
200912 1.953 90.703 2.210
201003 2.177 91.335 2.446
201006 1.973 91.809 2.206
201009 2.033 92.362 2.259
201012 2.172 92.836 2.401
201103 1.421 94.338 1.546
201106 1.345 94.654 1.458
201109 1.284 95.286 1.383
201112 1.785 94.970 1.929
201203 1.847 96.155 1.971
201206 1.779 96.076 1.900
201209 1.174 96.392 1.250
201212 1.239 95.760 1.328
201303 1.121 97.103 1.185
201306 1.039 97.182 1.097
201309 1.106 97.419 1.165
201312 1.115 96.945 1.180
201403 1.198 98.604 1.247
201406 1.255 99.473 1.295
201409 1.170 99.394 1.208
201412 1.105 98.367 1.153
201503 0.988 99.789 1.016
201506 1.305 100.500 1.333
201509 1.332 100.421 1.361
201512 1.225 99.947 1.258
201603 1.487 101.054 1.510
201606 1.288 102.002 1.296
201609 1.290 101.765 1.301
201612 1.200 101.449 1.214
201703 1.194 102.634 1.194

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merus Labs International  (NAS:MSLI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Merus Labs International Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines